Cargando…
Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ dif...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487417/ https://www.ncbi.nlm.nih.gov/pubmed/31089387 |
_version_ | 1783414497976778752 |
---|---|
author | Abolfazli, Seyyed Abolfazl Mohammadzadeh, Mehdi Peiravian, Farzad Zonoozi, Jafar Sharifnia, Hesam Vasheghani, Ali |
author_facet | Abolfazli, Seyyed Abolfazl Mohammadzadeh, Mehdi Peiravian, Farzad Zonoozi, Jafar Sharifnia, Hesam Vasheghani, Ali |
author_sort | Abolfazli, Seyyed Abolfazl |
collection | PubMed |
description | This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ different modes of strategy-making. It offers a typology of different modes of strategy-making that most likely exist in pharmaceutical companies and hypothesizes how this typology relates to performance. It then describes the results of an empirical study of the strategy-making processes of pharmaceutical companies. The structural equation analysis of the data from 31 pharmaceutical companies indicates that there are simplistic, adaptive, entrepreneurial, participative, and SPACE (Strategy making Process According to Complexity Environment) modes of strategy-making in pharmaceutical companies; of these modes, SPACE mode exhibited a significant relationship with performance. |
format | Online Article Text |
id | pubmed-6487417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-64874172019-05-14 Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry Abolfazli, Seyyed Abolfazl Mohammadzadeh, Mehdi Peiravian, Farzad Zonoozi, Jafar Sharifnia, Hesam Vasheghani, Ali Iran J Pharm Res Original Article This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ different modes of strategy-making. It offers a typology of different modes of strategy-making that most likely exist in pharmaceutical companies and hypothesizes how this typology relates to performance. It then describes the results of an empirical study of the strategy-making processes of pharmaceutical companies. The structural equation analysis of the data from 31 pharmaceutical companies indicates that there are simplistic, adaptive, entrepreneurial, participative, and SPACE (Strategy making Process According to Complexity Environment) modes of strategy-making in pharmaceutical companies; of these modes, SPACE mode exhibited a significant relationship with performance. Shaheed Beheshti University of Medical Sciences 2019 /pmc/articles/PMC6487417/ /pubmed/31089387 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Abolfazli, Seyyed Abolfazl Mohammadzadeh, Mehdi Peiravian, Farzad Zonoozi, Jafar Sharifnia, Hesam Vasheghani, Ali Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry |
title | Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry |
title_full | Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry |
title_fullStr | Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry |
title_full_unstemmed | Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry |
title_short | Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry |
title_sort | strategy-making process and firm performance in iranian pharmaceutical industry |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487417/ https://www.ncbi.nlm.nih.gov/pubmed/31089387 |
work_keys_str_mv | AT abolfazliseyyedabolfazl strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry AT mohammadzadehmehdi strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry AT peiravianfarzad strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry AT zonoozijafar strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry AT sharifniahesam strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry AT vasheghaniali strategymakingprocessandfirmperformanceiniranianpharmaceuticalindustry |